[1]
C. Barro, “The INCA trial: a multicenter, randomized, phase II, open-label clinical trial to evaluate the combination therapy with Ipilimumab plus Nivolumab versus Chemotherapy (Pemetrexate-Cisplatin) in patients with Advanced non-squamous NSCLC naive to treatment”, PPCR, vol. 4, no. 1, pp. 6-13, Jul. 2018.